Pharmaceuticals for use in the treatment of oncological, cardiological, dermatological, neurological, genetic, orthopedic and metabolic diseases and disorders.
FORMALIZED
on 31 May 2024
WELGLYCA
BRIDGEBIO PHARMA INC.
2330312 · 18 Mar 2024
005
Class 005
Pharmaceutical Products
Pharmaceuticals for use in the treatment of oncological, cardiological, dermatological, neurological, genetic, orthopedic and metabolic diseases and disorders.
Pharmaceuticals for use in the treatment of oncological, cardiological...
